CMND vs. NTBL, BDRX, BPTH, QLGN, PRFX, DRMA, ATNF, CNSP, GLMD, and INM
Should you be buying Clearmind Medicine stock or one of its competitors? The main competitors of Clearmind Medicine include Notable Labs (NTBL), Biodexa Pharmaceuticals (BDRX), Bio-Path (BPTH), Qualigen Therapeutics (QLGN), PainReform (PRFX), Dermata Therapeutics (DRMA), 180 Life Sciences (ATNF), CNS Pharmaceuticals (CNSP), Galmed Pharmaceuticals (GLMD), and InMed Pharmaceuticals (INM). These companies are all part of the "pharmaceutical preparations" industry.
Clearmind Medicine (NASDAQ:CMND) and Notable Labs (NASDAQ:NTBL) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment, analyst recommendations and community ranking.
Notable Labs has a consensus target price of $8.00, suggesting a potential upside of 540.00%. Given Notable Labs' higher possible upside, analysts plainly believe Notable Labs is more favorable than Clearmind Medicine.
Notable Labs' return on equity of -62.07% beat Clearmind Medicine's return on equity.
Notable Labs received 5 more outperform votes than Clearmind Medicine when rated by MarketBeat users.
In the previous week, Clearmind Medicine had 2 more articles in the media than Notable Labs. MarketBeat recorded 6 mentions for Clearmind Medicine and 4 mentions for Notable Labs. Clearmind Medicine's average media sentiment score of 0.77 beat Notable Labs' score of 0.72 indicating that Clearmind Medicine is being referred to more favorably in the media.
Clearmind Medicine has higher earnings, but lower revenue than Notable Labs.
96.1% of Clearmind Medicine shares are held by institutional investors. Comparatively, 70.5% of Notable Labs shares are held by institutional investors. 1.2% of Notable Labs shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Clearmind Medicine has a beta of 1.06, meaning that its share price is 6% more volatile than the S&P 500. Comparatively, Notable Labs has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500.
Summary
Notable Labs beats Clearmind Medicine on 7 of the 12 factors compared between the two stocks.
Get Clearmind Medicine News Delivered to You Automatically
Sign up to receive the latest news and ratings for CMND and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CMND and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Clearmind Medicine Competitors List
Related Companies and Tools
